Manikay Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,372,500
Closed -$136M 36
2019
Q3
$136M Sell
1,372,500
-107,500
-7% -$10.2M 14.21% 1
2019
Q2
$137M Buy
1,480,000
+511,000
+53% +$48.5M 11.37% 1
2019
Q1
$91.4M Buy
+969,000
New +$84.7M 11.28% 2

Other funds holding CELG

Manikay Partners's CELG Position: Q4 2019 in Review

Manikay Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,372,500 shares — an estimated $136M sold.

Manikay Partners first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $137M in Q2 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Manikay Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Manikay Partners sold 1,372,500 Celgene Corp shares in Q4 2019, an estimated $136M.
  • Manikay Partners first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • Manikay Partners's Celgene Corp position peaked at $137M in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Manikay Partners's 13F filing for Q4 2019, filed 14 Feb 2020.